Colloid solutions for fluid resuscitation in patients with sepsis: Systematic review of randomized controlled trials

Journal of Emergency Medicine

Volumn 45, Issue 4, 2013, Pages 485-495

  Zhong, Jing Zi ^a   Wei, Dan ^a   Pan, Hong Fei ^b   Chen, Yu Jun ^a   Liang, Xiu An ^a   Yang, Zhi Yong ^a   Tang, Hua Bo ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

colloids; fluid resuscitation; sepsis; systemic review

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH;

COLLOID; DISEASE SEVERITY; FLUID RESUSCITATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SEPSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

COLLOIDS; FLUID RESUSCITATION; SEPSIS; SYSTEMIC REVIEW;

ALBUMINS; COLLOIDS; DEXTRANS; FLUID THERAPY; GELATIN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84884671614     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2013.05.018     Document Type: Article

References (48)

1. A. Lever, and I. Mackenzie Sepsis: definition, epidemiology, and diagnosis BMJ 335 7625 2007 879 883
2. R.C. Bone A critical evaluation of new agents for the treatment of sepsis JAMA 266 1991 1686 1691
3. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
4. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
5. V.Y. Dombrovskiy, A.A. Martin, J. Sunderram, and H.L. Paz Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003 Crit Care Med 35 2007 1244 1250
6. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
7. Y. Sakr, M.J. Dubois, D. De Backer, J. Creteur, and J.L. Vincent Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock Crit Care Med 32 2004 1825 1831
8. M.H. Weil Current understanding of mechanisms and treatment of circulatory shock caused by bacterial infection Kansenshogaku Zasshi 53 1979 29 41
9. F. Schortgen, N. Deye, and L. Brochard Preferred plasma volume expanders for critically ill patients: results of an international survey Intensive Care Med 30 2004 2222 2229
10. R.J. Traylor, and R.G. Pearl Crystalloid versus colloid versus colloid: all colloids are not created equal Anesth Analg 83 1996 209 212
11. R.P. Dellinger, M.M. Levy, and J.M. Carlet Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 2008 17 60
12. J.L. Vincent, and H. Gerlach Fluid resuscitation in severe sepsis and septic shock: an evidence-based review Crit Care Med 32 Suppl. 2004 S451 S454
13. F. Bunn, D. Trivedi, and S. Ashraf Colloid solutions for fluid resuscitation Cochrane Database Syst Rev 1 2008 CD001319
14. C. Ertmer, S. Rehberg, H. Van Aken, and M. Westphal Relevance of non-albumin colloids in intensive care medicine Best Pract Res Clin Anaesthesiol 23 2009 193 212
15. S.F. Hussain, and P.J. Drew Acute renal failure after infusion of gelatins BMJ 299 6708 1989 1137 1138
16. F. Schortgen, J.C. Lacherade, and F. Bruneel Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study Lancet 357 9260 2001 911 916
17. F.M. Brunkhorst, C. Engel, and F. Bloos Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 2008 125 139
18. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560
19. J.L. Falk, E.C. Rackow, M.E. Astiz, and M.H. Weil Effects of hetastarch and albumin on coagulation in patients with septic shock J Clin Pharmacol 28 1988 412 415
20. G. Friedman, S. Jankowski, M. Shahla, J. Gomez, and J.L. Vincent Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients J Clin Anesth 20 2008 528 533
21. M. van der Heijden, J. Verheij, G.P. van Nieuw Amerongen, and A.B. Groeneveld Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia Crit Care Med 37 2009 1275 1281
22. S. Yacoub, H.J. Lang, and M. Shebbe Cardiac function and hemodynamics in Kenyan children with severe malaria Crit Care Med 38 2010 940 945
23. V.K. Puri, M. Howard, B.B. Paidipaty, and S. Singh Resuscitation in hypovolemia and shock: a prospective study of hydroxyethyl starch and albumin Crit Care Med 11 1983 518 523
24. D. Palumbo, G. Servillo, and L. D'Amato The effects of hydroxyethyl starch solution in critically ill patients Minerva Anestesiol 72 2006 655 664
25. P. Asfar Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study Intensive Care Medicine 26 2000 1282 1287
26. J. Boldt, M. Heesen, I. Welters, W. Padberg, K. Martin, and G. Hempelmann Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 75 1995 740 746
27. J. Boldt, M. Heesen, M. Muller, M. Pabsdorf, and G. Hempelmann The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients Anesth Analg 83 1996 254 261
28. J. Boldt, M. Mueller, T. Menges, M. Papsdorf, and G. Hempelmann Influence of different volume therapy regimens on regulators of the circulation in the critically ill Br J Anaesth 77 1996 480 487
29. J. Boldt, M. Muller, M. Heesen, K. Neumann, and G.G. Hempelmann Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients Crit Care Med 24 1996 385 391
30. J. Boldt, M. Muller, D. Mentges, M. Papsdorf, and G. Hempelmann Volume therapy in the critically ill: is there a difference? Intensive Care Med 24 1998 28 36
31. M. Dolecek, P. Svoboda, and I. Kantorova Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial Hepatogastroenterology 56 2009 1622 1628
32. Z. Molnar, A. Mikor, T. Leiner, and T. Szakmany Fluid resuscitation with colloids of different molecular weight in septic shock Intensive Care Med 30 2004 1356 1360
33. N.T. Ngo, X.T. Cao, and R. Kneen Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour Clin Infect Dis 32 2001 204 213
34. E.C. Rackow, J.L. Falk, and I.A. Fein Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock Crit Care Med 11 1983 839 850
35. E.C. Rackow, C. Mecher, M.E. Astiz, M. Griffel, J.L. Falk, and M.H. Weil Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion Crit Care Med 17 1989 394 398
36. R.J. Trof, S.P. Sukul, J.W. Twisk, A.R. Girbes, and A.B. Groeneveld Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia Intensive Care Med 36 2010 697 701
37. T.F. Veneman, J. Oude Nijhuis, and A.J. Woittiez Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial Wien Klin Wochenschr 116 9-10 2004 305 309
38. S.O. Akech, J. Jemutai, and M. Timbwa Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria Crit Care Med 38 2010 1630 1636
39. B.A. Wills, M.D. Nguyen, and T.L. Ha Comparison of three fluid solutions for resuscitation in dengue shock syndrome N Engl J Med 353 2005 877 889
40. S. Akech, S. Gwer, and R. Idro Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial PLoS Clin Trials 1 2006 e21
41. H.T. Huang, J.Y. Su, J.K. Chang, C.H. Chen, and G.J. Wang The early clinical outcome of minimally invasive quadriceps-sparing total knee arthroplasty: report of a 2-year follow-up J Arthroplasty 22 2007 1007 1012
42. M. Basora, V. Moral, J.V. Llau, and S. Silva [Perioperative colloid administration: a survey of Spanish anesthesiologists' attitudes] Rev Esp Anestesiol Reanim 54 2007 162 168
43. Zarychanski R, Turgeon AF, Fergusson DA, et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski, et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release. Open Med 2009;3(4):e196-209.
44. C.J. Wiedermann Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis BMC Emerg Med 8 2008 1
45. J. Boldt Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis Lancet 358 9281 2001 581 583
46. Boussekey N, Darmon R, Langlois J, et al. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care;14(2):R40.
47. M.C. Laxenaire, C. Charpentier, and L. Feldman [Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study] Ann Fr Anesth Reanim 13 1994 301 310
48. J. Ring, and K. Messmer Incidence and severity of anaphylactoid reactions to colloid volume substitutes Lancet 1 8009 1977 466 469